The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 331:270-271 July 28, 1994 Number 4
NextNext

Reproductive Technology -- The Price of Progress

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Each year more than a million American women use infertility services, but fewer than 50 percent of them go on to deliver a live baby1. Standard treatments for infertility include induction of ovulation, artificial insemination, and surgery for tubal disease or endometriosis. Little is known about why success with standard treatment for infertility is so limited; in many cases there may be reproductive deficiencies that are undetectable with current methods. Many couples are unable to reconcile themselves to the prospect of childlessness, and for them the scope of treatment has been altered dramatically by new techniques of assisted reproduction. . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.